NEULANDLAB

Neuland Laboratories LimitedNSE
₹23,995+1125.00 (+4.92%)

Market Closed · NSE · INR

Open

₹23,010

High

₹24,100

Low

₹23,010

Prev Close

₹22,870

52-Week Range100% from low
₹11,555
₹23,995

Market Cap

₹29.34 K Cr

Large Cap

P/E (TTM)

58.95

EPS

₹387.97

Div Yield

0.15%

P/B Ratio

16.42

ROE

26.6%

Key Metrics

Forward P/E46.59
Book Value₹1,461.02
Debt/Equity0.10×
Revenue Growth119.2%
Profit Margin20.99%
Operating Margin28.40%
Volume82.2 K
Avg Volume (20d)50.6 K
Delivery %34.70%
Trades26,795

Analyst Ratings(4 analysts)

-

Target Price

₹24,335

+1.4% upside

Buy4
Low: ₹23,300Median: ₹24,110High: ₹25,819

Current price: ₹23,995

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company...

neulandlabs.com2,183 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 46.00/share
23
24
25
26
24 Jul 202634.00
18 Jul 202512.00
12 Jul 202414.00
11 Jul 202310.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.